간세포암종에서 β-catenin의 핵 내 발현과 임상병리적 인자들과의 관계
Correlation of the Nuclear β-catenin Expression with the Clinicopathological Parameters of Hepatocellular Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the human liver. However, the molecular changes and mechanisms that regulate the development and progression of HCC remain unclear. Beta-catenin is known as a multi-functional protein that acts as a regulator of the cadherin-mediated cell-cell adhesion system and also in the Wingless/Wnt signal transduction pathway. The aim of this study was to investigate the expression of β-catenin and its possible role in HCC. Methods : We investigated the expression of β-catenin, Ki-67, TP53, α-smooth muscle actin and CD34 by performing immunohistochemical staining for 61 specimens of HCC and their adjacent non-tumorous tissue. We also examined the relationship between the nuclear expression of β-catenin and the clinicopathologic parameters. Results : The altered expression of β-catenin was not detected in the nontumorous liver tissue. The nuclear expression of β-catenin was observed in approximately 16%(10/61) of the HCC specimens. Double immunohistochemical staining for β-catenin and E-cadherin showed a close relationship between nuclear translocation of β-catenin and the loss of the membranous E-cadherin expression. Significant correlation was found between the nuclear translocation of β-catenin and the tumor size, tumor necrosis and the presence of microvessel invasion and intrahepatic metastasis (p<0.05). Conclusions : This data indicates that nuclear translocation of β-catenin could play a role in the growth and progression of HCC.
참고문헌 (25)
- Park JW, "Hepatocellular Carcinoma in Korea: introduction and overview", Korean J Gastroenterol, 45, pp.217~226 (2005)
- Nhieu JT, "Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation", Am J Pathol, 155, pp.703~710 (1999)
- Hugh TJ, "Beta-catenin expression in primary and metastatic colorectal carcinoma", Int J Cancer, 82, pp.504~511 (1999)
- Woo DK, "Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines", Int J Cancer, 95, pp.108~113 (2001)
- Haydon RC, "Cytoplasmic and", or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma, 2002, pp.102, 338~342
- Saito T, "Beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours", J Pathol, 195, pp.222~228 (2001)
- Behrens J, "Cadherins and catenins: role in signal transduction and tumor progression", Cancer Metastasis Rev, 18, pp.15~30 (1999)
- Ki Jung Yun, "Immunohistochemical Study of β-catenin Expression between Hepatocellular Carcinoma and Cholangiocarcinoma", Cancer Research and Treatment, 34(2), pp.117~121 (2002), 대한암학회
- Polakis P, "Wnt signaling and cancer", Genes Dev, 14, pp.1837~1851 (2000)
- Munemitsu S, "Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein", Proc Natl Acad Sci USA, 92, pp.3046~3050 (1995)
- Satoh S, "AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1", Nat Genet, 24, pp.245~250 (2000)
- Crawford HC, "The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors", Oncogene, 18, pp.2883~2891 (1999)
- Tetsu O, "Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells", Nature, 398, pp.422~426 (1999)
- He TC, "Identification of c-MYC as a target of the APC pathway", Science, 281, pp.1509~1512 (1998)
- Park YN, "Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis", Arch Pathol Lab Med, 124, pp.1061~1065 (2000)
- Cui J, "Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people", J Cancer Res Clin Oncol, 127, pp.577~581 (2001)
- 배시현, "간세포암의 조직학적 분화도및 임상적 특징에 따른 E-cadherin과 β-catenin의 발현 양상", Clinical and Molecular Hepatology, 8(2002), pp.297~303 (2002), 대한간학회
- Prange W, "Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes", J Pathol, 201, pp.250~259 (2003)
- Inagawa S, "Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival", Clin Cancer Res, 8, pp.450~456 (2002)
- MeeJoo, "Expression of β-catenin in Hepatocellular Carcinoma in Relation to Tumor Cell Proliferation and Cyclin D1 Expression", Journal of Korean Medical Science, 18(2), pp.211~217 (2003), 대한의학회
- Herath NI, "Cadherin", catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa, 2004, pp.19, 676~682
- Kozyraki R, "Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver", Gastroenterology, 110, pp.1137~1149 (1996)
- Asayama Y, "The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin", Liver, 22, pp.43~50 (2002)
- Wei Y, "Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features", Hepatology, 36, pp.692~701 (2002)
- Steele RJ, "The p53 tumour suppressor gene", Br J Surg, 85, pp.1460~1467 (1998)